<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <META NAME="ROBOTS" CONTENT="NOINDEX, NOFOLLOW">
    <link rel="icon" href="../images/logo/logo.png" type="image/x-icon">
    <link rel="shortcut icon" href="../images/logo/logo.png"
          type="image/x-icon">
    <title>浏阳德塔软件开发有限公司 女娲计划</title>
</head>
<body style="Max-width: 700px; text-align:center; margin:auto;">
<div style="text-align:left; Max-width: 680px; margin-left:15px;">
    <a href="../">上一页</a>
    <br/>
    <br/>
    <br/>第九章 DNA催化与肽展计算和AOPM-TXH-VECS-IDUQ元基解码
    <br/>The DNA Catalytic & PDE Computing and The Derivation of New TXH
    Initons DNA
    <br/>催化 与 肽展计算 和 AOPM-TXH-VECS-IDUQ 元基解码 013026 中文
    <br/>罗瑶光

    <br/>
    <br/>4. 推导与定义:AOPM-A变胸腺苷, AOPM-O尿胞变腺苷, AOPM-P尿胞变鸟苷,
    AOPM-M鸟腺苷的S形螺旋纹血氧峰触发器分子式催化计算严谨完整过程

    <br/>随着 VECS-IDUQ完整解码, AOPM就简单了. 准备描述下.
    <br/>作者已经拥有 肽展公式 A= V+ S, O= E+ S, P= E+ C, M= C+ S, 可以归纳为:AOPM-A
    变胸腺苷: 组合成份为 变感腺嘌呤 - 腺嘌呤 苷. AOPM-O 尿胞变腺苷: 组合成份为 尿变嘌呤 -
    腺嘌呤 苷. AOPM-P 尿胞变鸟苷: 组合成份为 尿变嘌呤 - 鸟嘌呤 苷. AOPM-M 鸟腺苷:组合成份为
    鸟嘌呤 - 腺嘌呤 苷.
    <br/>作者思考了下观测结构, 这种高级苷 可能存在 氢离子苷, 氮离子苷和氧离子苷,
    存在形态准备在下文中开始一一计算观测论证. 作者在这个时候进行描述下: 作者的思维推导能力
    来自于 在已经推导出来的 DNA 编码 1. 2. 2 和肽计算定理 1. 2. 2, 作者仅仅根据已知的
    结论进行拓展, 无法确定AOPM 的客观存在形式, 于是将所有可能存在的模型一一观测模拟论证如下.
    首先作者可以推论出在 DNA 计算中, 关于苷, 作者认为可以观测的模型可以有很多种, 因为这篇
    著作是生化计算的 研究推导, 不是生化建模和生化医药, 这篇文章不讨论.

    <br/>Derivation of pyrimidineMidazolo[1,2-a]pyrimidineMidazole
    <br/>About Derivation about 'S-arc' shape of 'AOPM-A, LTA', 'AOPM-O,
    UCLA', 'AOPM-P, UCLG', 'AOPM-M, GA', 'AOPM-OP-T, LTUCL', and
    'AOPM-OP-X, LTG'.
    <br/>First from the mentioned page of 152, A 分析(LTA 变胸腺腺苷), O 操作(UCLA
    尿胞变腺苷), P 处理(UCLG 尿胞变鸟苷), M管理(GA 鸟腺苷), V 感知(LT 变胸腺嘌呤), E
    执行(UCL 尿胞变嘌呤), C 控制(G 鸟嘌呤), S 静态(A 腺嘌呤), I 增加(U 尿嘧啶),
    D 减少(C 胞嘧啶), U 改变(L 变嘧啶), Q 感应(T 胸腺嘧啶).
    <br/>
    <br/>A-Analysis(LTA-Glycoside), O-Operation(UCLA-Glycoside),
    P-Process(UCLG-Glycoside), M-Management(GA-Glycoside),
    V-Vitionary(LT-Yaoguang-T-PI), E-Execute(UL-Yaoguang-PI),
    C-Control(G-Guanine Initon), S-Static(A-Adenine Initon),
    I-Increment(U-Uracil Initon), D-Decrement(C-Cytosine Initon),
    U-Update(L-Yaoguang Initons), Q-Query(T-thymine Initon).
    <br/>
    <br/>A spiral trigger flip-flops and its catalytic observation. Once
    the author did a proof of PDN extension formulas for A= V+S, O= E+ S,
    P= E+ C, M= C+ S. It could be concluded as 'A' equals to two purines
    combined with V and S, then did an observation of this structure of 'A'
    Initon, 'A' might contain Hybrogen-atom, Oxide-atom and Nitride-atom.
    Then did a proof of Its real-world sample. Finally proved a
    pyrimidineMidazolo[1,2-a]pyrimidineMidazole, was a common Initon's
    structure of A, O, P, M, T and X. Initially he found out four potential
    structures, which needed to be calculated of what was a true, and these
    proofs are needed by following an ordinary provided source, 1
    Nitride-parts position couldn't be changed of where in Midazolos, 2 It
    might need TWO fully pyrimidines to do a DNA base pair connected
    conditions, to distinct to the 'Steroid's which only had one base pair
    connected conditions, not two. Finally the author did a structure of
    pyrimidineMidazolo[1,2-a]pyrimidineMidazole, which resonated with
    author's thinking. And now these definitional structures catalyzed a
    Three-Initon-Char-Code-Nodes of PDC and PDW encodings. For example,
    AOP.POM.VEC. etc.
    <br/>
    <br/>The author connected his human literary structures were learned
    at school, for example SVO of subjects, predicates, and objects. He
    considered the DNA should had Its own literary 3 node-branches
    (Nouns, Verbs and Adverbs). Because the SVO could support structure of
    Nouns, Verbs and Adverbs, or a structure of Nouns, Adjectives and
    gerunds, those Three-Initon-Char-Code-Nodes of PDC and PDW encodes
    sample, see the original pages of 150, 153 and 154, refers '2020年10月31日
    8. 罗瑶光. 《肽展公式推导与元基编码进化计算以及它的应用发现》. 中华人民共和国国家版权局,
    国作登字-2021-A-00042587.
    2021. ' and '2020年10月09日 7. 罗瑶光, 罗荣武. 《类人DNA与 神经元基于催化算子映射编码方式
    V_1. 2.
    2》. 中华人民共和国国家版权局, 国作登字-2021-A-00097017. 2021.' The author YaoguangLuo
    稍后优化语法.
    <img class="banner_img" style="width: 100%" src="../images/5_7108/9/9_8.jpg"
         alt="浏阳德塔软件开发有限公司,罗瑶光"/>

    <br/>Figure 4
    <br/>
    <br/>关于元基的降解 聚合 变换, 起主导作用仍是 变嘧啶(甲基胞嘧啶) 作为肽钥匙, 在血氧峰
    心跳时钟 下 做酸碱触发器信号的 数字逻辑计算. 大体归纳出图中右边 4 种重要特征属性类.
    作者通过上图左边进行的嘌呤结构进行元基催化解码定义, 发现了 4 种结构, 右边从上到下 前
    2 个因为的氮基的位移错误于是不讨论, 则有右下 2 个 possible 可能, 上旋弧和下旋弧.
    于是开始跟进推导计算观测论证它的具体定义.
    <br/>

</div>
</body>